$ZETAAug 5, 2026, 9:34 AM ETAI processed

Expedition Therapeutics raises $115M Series B; ZETA CEO to discuss Q2 beat-and-raise

AI Summary

Expedition Therapeutics secured a $115 million Series B and says first patients have been dosed in its Phase 2 trial of EXPD-101 for COPD, marking both a financing and clinical progress milestone. Separately, Zeta Global (ZETA) CEO will appear on NYSE Live to discuss the company's Q2 report, which Zeta said was its 20th consecutive 'beat-and-raise' quarter and achieved the firm’s cited 'Rule of 64.'

Positives

Expedition closed a $115M Series B financing
Company reports first patients dosed in Phase 2 trial of EXPD-101 for COPD
Zeta Global reports 20th consecutive beat-and-raise quarter and will present Q2 takeaways on NYSE Live

Negatives

No efficacy data, cohort size, or detailed Phase 2 endpoints were disclosed in the update
Expedition is a private financing event, limiting direct immediate market impact for public equity investors

Company Info

Company:: Zeta Global Holdings Corp
Exchange:: NYSE
Industry:: Technology
Country:: US
Website:: https://investors.zetaglobal.com
Market cap:: 5.33B
Shares outstanding:: 249.26M

Now available

TradersLink Beta App

Free beta access for all TradersLink Discord members(free and premium members)

Session Tracker

Enter the executions you took each day and TradersLink builds the trades for you. Review them by ticker with trade replay charts, then add trade notes, tags, and rules. Finish the day with what went well, what to work on, and your main focus for next time.

Trade Analyzer

Analyze every trade—not just your totals. Review detailed entry, exit, and complete-trade analysis, then use long-term results to study your execution habits over time. See missed profit opportunities, exits that may have happened too early, and trades that were green before they finished red. Candle-pattern data helps you study the conditions around your entries and exits.

Smart Rules

Use preset trading rules that TradersLink can track from your recorded trades. Review when a rule may have been broken, see your results over time, and create custom rules for your own process.

Press Release Alerts

Get press-release alerts inside your dashboard, including alerts when a stock is halted, so important news is visible while you track your trades.

Trade Explorer

Open a completed trade and go deeper. Review its executions, result, notes, tags, rules, and analysis in one place.

Analytics

Understand your trading history from more than one angle. Explore results by ticker, time of day, holding time, setups, and other patterns supported by your recorded trades.